Atomoxetine (Strattera) was approved by the FDA for ADHD treatment in 2002, but how effective is it and where does it stack up against other treatments?
CME: Take the CME Post-Test for this episode
Published On: 06/27/2022
Duration: 13 minutes, 38 seconds
Referenced Article: “Atomoxetine for Children and Adolescents: An Update,” The Carlat Child Psychiatry Report, January/February/March 2022
Joshua Feder, MD, and Mara Goverman, LCSW, have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
No transcript available.
POWERED BY BLUBRRY
